Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Summary of Latest Ratings, TPs, Views on GALAXY ENT from Brokers
Recommend 21 Positive 36 Negative 18 |
||||
|
||||
|
AASTOCKS Financial News has compiled the latest investment ratings and target prices for GALAXY ENT (00027.HK) from six brokers, with key views summarized as follows: Brokers | Ratings | TPs (HKD) | Core Views Goldman Sachs | Buy | 53.2 | 1Q results met expectations. Market share in GGR rebounded in April and May. Dividend level provides downside support for the share price. HSBC Research | Buy | 48.5 | 1Q margin beat. The company defended market share through precise marketing strategies while maintaining cost discipline. Continued growth of Capella at Galaxy Macau and Horizon Plus in Macau will support EBITDA growth this year. CLSA | Outperform | 47.4 | Results met expectations. Net cash reached as high as USD4.67 billion, with capex expected to peak in 2026. UBS | Buy | 46 | 1Q adjusted EBITDA met expectations. EBITDA margin improved after adjusting for win rate. Although the World Cup may affect short-term traffic, the company arranged events in response. Morgan Stanley | Equalweight | 39 | 1Q results met expectations. Operating expenses remained disciplined. Citi | Buy | 52 | 1Q results met expectations. Core gaming business EBITDA still recorded YoY growth. Both mass and VIP GGR increased. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
